Pulmonx Corp Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Pulmonx Corp Stock Summary

Pulmonx Corp competes with Iradimed, Orthofix Medical, Neuropace, Integer Holdings, and CONMED. Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California. Pulmonx Corp operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 253 people.

Pulmonx Corp Key Financial Ratios

Pulmonx Corp Key Balance Sheet Accounts

Pulmonx Corp Key Income Statement Accounts

Pulmonx Corp Key Cash Accounts

Pulmonx Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Pulmonx Corp's current stock value. Our valuation model uses many indicators to compare Pulmonx Corp value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Pulmonx Corp competition to find correlations between indicators driving Pulmonx Corp's intrinsic value. More Info.Pulmonx Corp is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Pulmonx Corp's Return On Equity is most likely to slightly decrease in the upcoming years. Comparative valuation analysis is a catch-all technique that is used if you cannot value Pulmonx Corp by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Pulmonx Corp Systematic Risk

Today, most investors in Pulmonx Corp Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Pulmonx Corp's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Pulmonx Corp growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Pulmonx Corp help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Pulmonx Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Pulmonx Corp based on widely used predictive technical indicators. In general, we focus on analyzing Pulmonx Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Pulmonx Corp's daily price indicators and compare them against related drivers.

When running Pulmonx Corp's price analysis, check to measure Pulmonx Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pulmonx Corp is operating at the current time. Most of Pulmonx Corp's value examination focuses on studying past and present price action to predict the probability of Pulmonx Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pulmonx Corp's price. Additionally, you may evaluate how the addition of Pulmonx Corp to your portfolios can decrease your overall portfolio volatility.